KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 146 filers reported holding KARYOPHARM THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 3.32 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $68,303 | -53.9% | 38,053 | -0.2% | 0.00% | – |
| Q1 2023 | $148,077 | +256.7% | 38,114 | +212.6% | 0.00% | – |
| Q4 2022 | $41,518 | -37.2% | 12,194 | -50.0% | 0.00% | – |
| Q3 2022 | $66,066 | +20.1% | 24,390 | +99.6% | 0.00% | – |
| Q2 2022 | $55,000 | -38.9% | 12,220 | +0.5% | 0.00% | – |
| Q1 2022 | $90,000 | +15.4% | 12,163 | +0.0% | 0.00% | – |
| Q4 2021 | $78,000 | -99.9% | 12,162 | -99.6% | 0.00% | -100.0% |
| Q1 2020 | $62,487,000 | – | 3,252,828 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AIGH Capital Management LLC | 1,773,474 | $2,376,456 | 1.12% |
| AlphaCentric Advisors LLC | 1,125,000 | $1,507,500 | 0.86% |
| Tejara Capital Ltd | 1,077,388 | $1,443,700 | 0.82% |
| Palo Alto Investors LP | 5,675,876 | $7,605,674 | 0.72% |
| Birchview Capital, LP | 571,832 | $766,255 | 0.65% |
| Altium Capital Management LP | 740,000 | $991,600 | 0.52% |
| Avidity Partners Management LP | 8,298,570 | $11,120,084 | 0.45% |
| Worth Venture Partners, LLC | 445,981 | $597,615 | 0.36% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 561,955 | $753,020 | 0.23% |
| DAFNA Capital Management LLC | 192,678 | $258,189 | 0.08% |